KANSAS CITY, MO (KCTV) -- The maker of a popular coronavirus vaccine says similar technology could be used to tackle other dangerous viruses.
Moderna announced it will use its messenger RNA technology for experimental treatments of the seasonal flu, H.I.V. and the Nipah virus.
The pharmaceutical company believes its MRNA technology could help treat viruses that have, quote, "eluded traditional vaccine efforts."
Human trials on Moderna's flu vaccines are expected to begin later this year. The company also plans to begin clinical trials for two experimental vaccines against H.I.V. later this year.